The report provided the industry with several critical tools: A Standard Protocol
The report focuses on (solutions, suspensions, emulsions) and medical devices , particularly those containing surfactants, preservatives, chelators, or lipids—formulations known to mask endotoxin activity. pda technical report 82
LER occurs when spiked endotoxins in certain biologics cannot be fully recovered or detected during testing, even when using the standard assay. This masking typically happens in biopharmaceutical formulations that combine: Surfactants (like Polysorbate 80) Chelating agents (such as citrate or phosphate buffers) The report provided the industry with several critical
The report was developed by a task force including experts from the U.S. FDA and the pharmaceutical industry to address the following: FDA and the pharmaceutical industry to address the
TR 82 serves as a defense for companies utilizing this non-standard method. During an inspection, a regulator may question why a water system is sanitized at low velocity.